SCHEMBL24475600

SCHEMBL24475600

c1ccc(-c2ccc(-c3ccc4ccc(-c5ccc6ccc(-c7ccc8cc(-c9ccc%10ccc%11cccnc%11c%10n9)ccc8c7)nc6c5)cc4n3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 7/20 0.50
CYP17A1 P05093 1/20 0.43
CYP19A1 P11511 1/20 0.43
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
KDM4E B2RXH2 2/20 0.42
NFKB1 P19838 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
GMNN O75496 1/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
HSP90AA1 P07900 1/20 0.42
MMP2 P08253 1/20 0.42
MAPT P10636 1/20 0.42
MMP9 P14780 1/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
MMP8 P22894 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22281897 0.99 TOP1 (0.51) TOP1CYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL24475477 0.96 TOP1 (0.47) TOP1CYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL24454118 0.96 TOP1 (0.46) TOP1CYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL22970162 0.96 TOP1 (0.51) TOP1CYP3A4CYP2D6KDM4ENFKB1
SCHEMBL22281889 0.96 TOP1 (0.54) TOP1CYP3A4CYP2D6KDM4ENFKB1
SCHEMBL24475572 0.95 TOP1 (0.45) TOP1CYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL22282133 0.95 TOP1 (0.48) TOP1CYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL24475769 0.95 TOP1 (0.50) TOP1CYP3A4CYP2D6KDM4ENFKB1
SCHEMBL24475473 0.95 TOP1 (0.46) TOP1CYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL24453758 0.95 TOP1 (0.55) TOP1CYP3A4CYP2D6KDM4ENFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220173329-A1 COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE LT MATERIALS CO., LTD. (KR) 2022-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220173329-A1 COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE OXER1, OCIAD1, OR10J3 TOP1 3936/4885CYP17A1 204/4885CYP19A1 289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.